Simple Non-Invasive Test Predicts Heart Risk In Postmenopausal Women

Main Category: Cardiovascular / Cardiology
Also Included In: Women's Health / Gynecology
Article Date: 18 Apr 2008 - 2:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:5 stars

4.67 (3 votes)

Healthcare Prof:not yet rated


Endothelial dysfunction is a disordered function of very small coronary vessels that cannot be seen by angiograms done during cardiac catheterization. The impairment of endothelial function is the primary etiology implicated in the origin and development of atherosclerosis. In a prospective study of 2264 post-menopausal women, endothelial function was measured by utilizing the noninvasive measurement of the brachial artery flow characteristics. When added to age and other conventional cardiovascular risk factors (smoking habits, presence of hypercholesterolemia, history of diabetes, hypertension), endothelial dysfunction contributed significantly to predicting heart risk. {Journal of the American College of Cardiology, V. 51, No. 10 (11 March 2008), pp. 997-1002}. L-arginine, an amino acid, promotes healthy blood vessels by its antioxidant properties and reducing endothelial dysfunction.(a)

Advanced Cardiac Life Sciences, LLC (ACLS), is pleased to announce the continued success of CardioVance® and CardioVance.com, offering educational resources and evidence-based nutritional supplementation for women's heart health. CardioVance® is cardiologist-formulated for women concerned about heart health. CardioVance's development stems from increasing consumer demand to optimize heart health naturally while at the same time applying scientific rigor to the development of nutritional supplementation.

CardioVance® helps women to improve endothelial dysfunction, maintain normal blood pressure and cholesterol, and promote a healthy cardiovascular system by incorporating Omega-3 Fish Oils, CoEnzyme Q10, L-arginine, Calcium and Vitamin D, and a powerful multivitamin into a convenient daily nutrition pack.(a)CardioVance.com advances the fight against women's heart disease, empowers women through educational resources, and incorporates evidence-based science into nutritional supplementation.

For additional information or details concerning marketing CardioVance®, visit http://www.cardiovance.com. CardioVance is a Registered Trademark of Advanced Cardiac Life Sciences, LLC.

(a)These statements have not been reviewed by the Food and Drug Administration. This product should be taken as part of a healthy lifestyle and is not intended to diagnose, treat, cure, or prevent any disease.

CardioVance

Article adapted by Medical News Today from original press release.
Visit our cardiovascular / cardiology section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
CardioVance. "Simple Non-Invasive Test Predicts Heart Risk In Postmenopausal Women." Medical News Today. MediLexicon, Intl., 18 Apr. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/104460.php>

APA
CardioVance. (2008, April 18). "Simple Non-Invasive Test Predicts Heart Risk In Postmenopausal Women." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/104460.php.

Please note: If no author information is provided, the source is cited instead.




Cardiovascular / Cardiology

What Is Heart Rate?

A person's heart rate, also known as their pulse, refers to how many times their heart beats per minute. Our heart rates vary tremendously, depending on the demands we make on our bodies. Read more...

Most Popular Articles



Follow Our Cardiovascular News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cardiovascular / Cardiology Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »